#VisualAbstract: Neoadjuvant chemotherapy plus surgery improves overall survival compared to surgery alone in locally advanced esophageal cancer
Click to read this study in the European Journal of Cancer.
Tag: esophageal cancer
#VisualAbstract: Positron emission tomography effective at assessing early tumor response to induction chemotherapy in esophageal or esophagogastric junction cancers
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Head and neck cancers are highly prevalent among alcohol consumption-associated malignancies in the global population
Click to read the study in The Lancet Oncology.
#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas
Click to read the study in The Lancet.
#VisualAbstract: Concurrent S-1-based chemoradiotherapy improves survival compared to radiotherapy alone in older patients with esophageal cancer
Click to read the study in JAMA Oncology.
#VisualAbstract: Induction chemotherapy may improve survival in patients with esophageal adenocarcinoma
Click to read the study in the European Journal of Cancer.
Adjunctive nivolumab reduces risk of death and progression of gastric adenocarcinoma compared to chemotherapy alone
1. Overall survival and progression-free survival were higher for patients on nivolumab plus chemotherapy compared to chemotherapy alone. 2. Severe ...
#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer
Click to read the study in the Journal of Clinical Oncology.
Neoadjuvant chemoradiotherapy plus surgery increases overall survival of patients with advanced esophageal squamous cell carcinoma compared to surgery alone
1. Neoadjuvant chemoradiotherapy (NCRT) with surgery improves the death rate, overall survival, disease-free survival time, and locoregional and distal recurrence ...